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Abstract
There is considerable interest in the discovery of peptide ligands that bind to protein targets. 
Discovery of such ligands is usually approached by screening large peptide libraries. However, the 
individual peptides must be tethered to a tag that preserves their individual identities (e.g. phage 
display or one-bead one-compound). To overcome this limitation, we have developed a method for 
screening libraries of label-free peptides for binding to a protein target in solution as a single 
batch. The screening is based on decreased amide hydrogen exchange by peptides that bind to the 
target. Hydrogen exchange was measured by mass spectrometry. We demonstrate the approach 
using a peptide library derived from the E. coli proteome that contained 6664 identifiable features. 
The library was spiked separately with a peptide spanning the calmodulin binding domain of 
endothelial nitric oxide synthase (eNOS, 494-513) and a peptide spanning the N-terminal twenty 
residues of bovine ribonuclease A (S peptide). Human calmodulin and bovine ribonuclease S 
(RNase S) were screened against the library. Using a novel data analysis workflow we identified 
the eNOS peptide as the only calmodulin binding peptide and S peptide as the only ribonuclease S 
binding peptide in the library.
Introduction
The discovery of novel peptide ligands against proteins targets facilitates research in 
disciplines ranging from basic sciences to drug and vaccine discovery. Peptides that bind to 
cell surface proteins can be used as cell-specific probes for imaging, either as an alternative 
to immunohistochemistry or in in vivo contexts, or for the targeted delivery of chemical 
agents.1 Specific interaction surfaces between proteins can be blocked by peptides that 
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function as inhibitors of protein-protein interactions.2 Peptides also act as allosteric 
modulators.3,4 Peptides ligands can be used to define hot-spots on protein surfaces5 that can 
subsequently be explored and optimized through medicinal chemistry efforts exploiting 
either small molecule or peptidomimetic approaches.6 Screening peptide libraries against 
antibodies is invaluable in epitope mapping.7
The development of peptide libraries against a target of interest can be divided into two 
categories: libraries developed in vivo through genetic approaches and chemically 
synthesized libraries. The most common genetic approaches are phage display and bacterial 
display.8-10 Here, large libraries of random peptides (∼1010) are exposed on the surfaces of 
phage or bacterial cells as inserts or tails within specific surface proteins. Multiple rounds of 
affinity selection (i.e., biopanning) are used to select amino acid sequences that have high 
affinity for the target. The ligands are then identified by DNA sequencing. Chemically 
synthesized libraries are usually prepared using combinatorial chemistry.1 In the one-bead 
one-compound (OBOC) approach, peptides are synthesized combinatorially such that each 
individual bead has a unique sequence immobilized on its surface.11 In positional scanning 
libraries, mixtures of combinatorially synthesized peptides are holistically screened for 
binding.12 Multiple rounds of iterative screening of progressively less diverse mixtures can 
then produce unique peptide ligands. One advantage of chemically-synthesized libraries is 
that it is easy to include unnatural amino acids, those other than the twenty naturally-
occurring L forms.
A number of different approaches are available to screen peptide libraries for binding to a 
target of interest. The approaches can either be based on direct detection of binding, indirect 
detection through displacement, or a functional readout such as enzymatic activity or cell 
viability.13 With small libraries, screening can be carried out one peptide at a time or with 
individual peptides isolated in an addressable array. For large libraries such as those 
generated in phage display, screening must done in one pot. Thus the challenge becomes 
discovery of those peptides that bind to the target in a mixture of similar peptides that do not 
bind. With phage and bacterial display, multiple rounds of biopanning are used to identify 
the highest affinity sequences. In one-bead one-compound, the individual beads are screened 
for binding and mechanically sorted; the peptides that exhibit binding are subsequently 
identified by Edman sequencing or mass spectrometry.14
A major limitation of both peptide display and one-bead one-compound approaches is that 
the screened peptides must carry some type of genetic or chemical tag to facilitate 
identification. In the peptide display approaches, either or both the N- and C-termini are 
tethered; in chemically-synthesized libraries, one terminal will be tethered. Addition of these 
tags can interfere with binding to the target, either preventing binding or promoting 
artefactual binding. The current state-of-the-art does not permit the direct, one-pot screening 
of free peptides in solution for binding to a protein target. Our work directly addresses this 
limitation. Here, we demonstrate a one-pot screening approach to identify peptides from 
arbitrary libraries of intermediate size (<104 peptides) that bind to a specific protein target. 
Target binding is detected by amide hydrogen exchange mass spectrometry (HX-MS) 
analysis of the peptides. Another unique feature of this work is that the peptide library was 
generated using a proteomic approach: the peptide library was obtained by multi-enzyme 
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proteolysis of the E. coli proteome. We demonstrate proof-of-concept by selective detection 
of the binding of two target proteins, calmodulin and ribonuclease S, with their peptide 
ligands.
Experimental
Preparation of the E. coli peptidomic library
E. coli BL21(DE3) transformed with a pET22b plasmid described previously 15 was grown 
as follows. A single colony was selected from an ampicillin/LB agar plate that had been 
streaked with the glycerol stock and incubated overnight at 37 °C. The colony was used to 
inoculate 10 mL of LB medium containing 100 μg mL−1 ampicillin. The starter culture was 
grown for 10 hr at 37 °C in an orbital shaker operating at 225 rpm. The starter culture was 
added to 200 mL of LB medium containing 100 μg mL−1 ampicillin. The culture was 
incubated at 37 °C in an orbital shaker operating at 225 rpm. Cells were harvested at OD600 
= 1.0. The culture was split into 40 mL portions and pelleted at 10000 × g for 10 min at 
4 °C. After discarding the supernatant, the pellets were stored at −80 °C. Cell pellets were 
resuspended in 50 mM ammonium bicarbonate buffer (pH 8.0) containing 10% acetonitrile 
by volume, protease inhibitors (cocktail set VII, Calbiochem, San Diego, CA, USA), and 10 
units of DNase-RNase mix (GE Healthcare Biosciences, Pittsburgh, PA, USA). The cells 
were subjected to three freeze-thaw cycles (liquid nitrogen/37 °C) then briefly probe 
sonicated (Microson ultrasonic cell disruptor XL2000, Misonix Inc., Farmingdale, NY, 
USA) on ice for 5 s using lowest power setting. The lysate volume was diluted 1:1 with 6 M 
urea in 50 mM ammonium bicarbonate buffer (pH 8.0). The cell lysate was then subjected to 
three additional freeze-thaw cycles. The crude lysate was clarified by centrifugation at 
17000× g for 20 min at 4 °C. Proteins were precipitated from the clarified lysate with 4 
volumes acetone at −20 °C. The total protein content of the acetone-precipitated fraction 
was estimated using the bicinchoninic acid assay (ThermoFisher Scientific, Rockford, IL, 
USA).
Proteins in the acetone-precipitated fraction were digested with several different proteases 
using a modified version of the filter-aided sample preparation (FASP) process.16-20 
Precipitated proteins were dissolved in 50 mM ammonium bicarbonate buffer (pH 8.0) 
containing 10% acetonitrile and 6 M urea, reduced with dithiothreitol (40 mM for 1 hr at 
37 °C) and then alkylated with iodoacetamide (80 mM for 0.5 hr at 23°C in the dark). Three 
protein samples (350 μg each) were loaded onto separate centrifugal microconcentrators (10 
kDa cut-off, Low-binding Microcon Centrifugal Filter Devices, Ultracel YM-10, Millipore, 
Bedford, MA, USA). The sample buffer, containing reducing and alkylating agents, was 
removed by centrifugation. In the following steps, the liquid sample was collected from the 
concentrator by centrifugation at 14,000×g at 20 °C, Centrifugation was applied until visual 
inspection of the concentrator showed that the elution step was complete (typically 15-30 
min). For the digestion steps, peptides were collected by retaining the concentrator flow-
through. The sequence of digestions steps, described in detail here, is also shown in 
Supporting Figure S1. The samples were digested overnight at 37 °C with endoproteinases 
LysC (Promega, Madison, WI, USA), Glu-C (Protea Biosciences, Morgantown, WV, USA), 
and Asp-N (Promega, Madison, WI, USA) at an enzyme:protein ratio of 1:50 in 100 μL of 
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50 mM ammonium bicarbonate (pH 8.0) containing 10% acetonitrile and either 1 M urea 
(for Glu-C and Asp-N digestions) or 6 M urea (for Lys-C digestion). After recovering the 
peptides, an additional 100 μL of digestion buffer was added and the samples were digested 
for an additional 3 hr at 37 °C. After recovering the peptides, trypsin (Promega, Madison, 
WI, USA), at an enzyme:protein ratio of 1:50, was then added to all three samples for 
overnight digestion at 37 °C in 100 μL of 50 mM ammonium bicarbonate (pH 8.0) 
containing 10% acetonitrile with 1 M urea. After recovering the peptides, the Lyc-C 
digested-sample was further digested with Glu-C (at an enzyme:protein ratio of 1:50) for 3 
hr at 37 °C. After recovering the peptides, an additional 100 μL of digestion buffer was 
added to all three samples and for 3 additional hours of digestion. Ultimately, all of the 
peptides liberated by centrifugation at each step were pooled into a single sample. The 
library was sub-aliquoted and then vacuum dried on an evaporative concentrator for 2 hours 
at 30 °C (Freezone model 7670521, Labconco, Kansas City, MO, USA).
LC-MS
All MS measurements were made with a quadrupole-time of flight mass spectrometer 
(Agilent 6530, Santa Clara, CA, USA) interfaced to a multi-pump LC system (Agilent 1200 
series, Santa Clara, CA, USA). Liquid handling and valve switching was performed by a 
robotic liquid handler (LEAP HDX PAL, LEAP Technologies, Carborro, USA). LC 
separations consisted of online desalting and concentration on a C8 trap (Poroshell 120 EC-
C8, 2.1 × 5 mm, 2.7 μm particles, Agilent, Santa Clara, CA, USA) with 0.1% formic acid at 
200 μL min−1 followed by gradient elution at 200 μL min−1 through a C18 column (Zorbax 
300SB-C18, 1.8 μm particles, 2.1 × 50 mm, Agilent Technologies, Santa Clara, CA, USA) 
using a water/acetonitrile gradient with both mobile phases containing 0.1% formic acid.
Peptides in the E. coli library were identified in a series of runs using data-dependent MS2 
with collision-induced dissociation. Initial feature extraction was performed in MassHunter 
Qualitative analysis (Agilent, Santa Clara, CA, USA). Mass spectral features were exported 
as .mgf files. Feature identification was performed using PeptideShaker (version 0.37.7, 
http://compomics.github.io/projects/peptide-shaker.html) proteomic informatics analysis 
software.21 Peptides were identified using a concatenated target-decoy E. coli FASTA-
formatted protein sequences database from UniProt using the algorithms X! TANDEM, 
OMSSA, MyriMatch, MS-GF+ and MS Amanda. The decoy database sequences, a reversed 
version of the E.coli sequences, was created using SearchGUI (version 1.30.1, http://
compomics.github.io/projects/searchgui.html). Validation at a 1% false discovery rate was 
obtained by searching against the decoy database. The search was performed in parallel 
using each of the proteases trypsin, LysC, GluC, AspN allowing for up to two missed 
cleavages, up to 8 modifications a precursor mass tolerance of 20 ppm and fragment mass 
tolerance of 0.05 u.
Screening
Human calmodulin, a gift from Prof. Trevor Creamer (University of Kentucky), was 
expressed and purified as described previously.22,23 The calmodulin binding domain of 
human endothelial nitric oxide synthase (eNOS, 494-513, hereafter “eNOS peptide”, 
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RKKTFKEVANAVKISASLMG), was obtained from Anaspec (Freemont, CA, USA) as a 
lyophilized powder at >95% purity.
Bovine ribonuclease S was obtained from Sigma (St. Louis, MO, USA). Ribonuclease S is a 
complex between the protein and a twenty-residue peptide (S peptide). The protein fraction 
was isolated from the peptide using the tricholoracetic acid precipitation method described 
by Richards.24 RNase S at 1 mg mL−1 in 20 mM HEPES / 100 mM NaCl / 10 mM CaCl2 
pH 7.5 was precipitated on ice with one-fifth volume of 20% (w/v) trichloroacetic acid and 
then incubated for one hour at room temperature. After centrifugation and removal of the 
supernatant, the RNase S pellet was reconstituted in H2O, dialyzed overnight at 4 °C against 
the original HEPES buffer, and then lyophilized. Synthetic S peptide 
(KETAAAKFERQHMDSSTSAA) was obtained from GenScript (Piscataway, NJ, USA) as 
a lyophilized solid at >85% purity and used without further purification.
Calmodulin and RNase S (the target proteins) were separately screened for binding to their 
respective peptide ligands in the presence and absence of E. coli-derived peptide libraries. 
Prior to screening, we deuterated the peptides, either 2 μM eNOS peptide or S peptide alone 
or spiked into the E. coli library, in 25% D2O [20 mM MES, 10 mM CaCl2, 100 mM NaCl, 
pH 5.95] for 1 hr at 22 °C. Next, stock calmodulin and RNase S prepared from lyophilized 
solids, in 20 mM MES, 10 mM CaCl2, 100 mM NaCl, 100 % D2O pH 5.94 was added to 
reach 8 μM. In protein-free preparations, an equal volume of the buffer was substituted. Four 
mixtures were prepared: neat peptide, neat peptide and protein, peptide library, and peptide 
library and target protein. These mixtures were allowed to equilibrate for at least 1 hr at 1 °C 
prior to use. The combination of 25% D2O from the peptide library and 100% D2O from the 
target protein resulted in 40% D2O in the mixtures. Labeling reactions were automated using 
a robotic liquid handler (LEAP HDX PAL, Carborro, NC, USA). 5 μL aliquots of the 
peptide stocks, held at 1 °C, were dispensed into individual autosampler vials. D → H 
exchange at 4 °C for 60 s was initiated by addition of 45 μL of H2O buffer. 40 μL of the 
labeling mixture was quenched by mixing with an equal volume of quench buffer (200 mM 
glycine pH 2.5 at 1°C). After a 15 s hold at 1 °C, 70 μL of the quenched reaction mixture 
was loaded into the sample loop of the LC system. The temperature of the mobile phase, 
columns, and tubing was maintained at 1 °C using the refrigerated column compartment of 
the HDX PAL system. Screening reactions were run in triplicate. To minimize the 
complexity without complete loss of deuterium label, the labeling reactions were run using 
each of three different short gradients as described in further detail in the Results section 
resulting in a total of 36 labeling reactions (4 conditions × 3 gradients × 3 replicates) for 
each target protein screening.
Data analysis
Initial MS feature extraction was carried out using the Find by Molecular Feature algorithm 
in MassHunter Qualitative Analysis (version B.06, Agilent, Sana Clara, CA, USA). 
Deuterated peptide features have isotopic distribution patterns that are very different than 
peptides with a natural isotopic distribution. Initially, trial and error was used to adjust the 
algorithm parameters to reliably extract the spectra of deuterated eNOS peptide (see Table 
S3 in the Supporting Information). Extracted features lists, as .cef files, were further 
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analyzed using MassProfiler (version B.03.00, Agilent Santa Clara, CA, USA). MassProfiler 
is typically used to identify biomarkers in large data sets that are unique to a particular 
experiment. In the present case, a feature that appears at the same mass and retention time in 
the presence and absence of target protein was taken to be a non-binder. As with feature 
extraction, trial and error was required to optimize MassProfiler parameter settings to 
reliably return data for the eNOS peptide. (See Table S4 in the Supporting Information for 
the optimized parameter settings.) The output of MassProfiler was a list of features that 
appeared to be unique, i.e., they appeared to be present only in either the presence or 
absence of the target protein. This list of features was further analyzed to identify potential 
target binders as described in the Results section. This data analysis workflow was used 
without any further optimization for the screening of RNase S.
Results
Peptide library production
To test the feasibility of peptide library screening, we first developed a peptide library from 
E. coli lysate by combining sequential and parallel treatments with Lys-C, Glu-C, Asp-N, 
and trypsin using a filter-aided sample preparation (FASP) protocol as described in the 
Experimental section. In this context, sequential means that after treatment with a protease 
(e.g., Glu-C), the released peptides, as filter flow-through, were collected. The filter retentate 
was then treated with an additional protease (e.g, trypsin). Parallel means that different 
sequential digestions of the same lysate were carried out on separate filter units.
We used parallel FASP-based digestions starting with Asp-N, Glu-C, and Lys-C as shown in 
Figure S1. Trypsin was then added as a second protease to all of the filter units. In the Lys-
C/trypsin digestions, Glu-C was used as a third, complimentary, protease. Peptides from all 
three digestions were pooled into a single peptide library containing, based on LC-MS 
analysis, 6200 putative peptides. The pooled library was analyzed several times by LC-MS2. 
While our LC-MS system was not optimized for proteomic work (see Experimental) our 
objective here was simply to gain a general overview of the proteome coverage that could be 
obtained. The results from this analysis are shown in Table 1: a total of 45419 extracted MS 
features produced 40241 MS2 spectra. Analysis using PeptideShaker produced 5646 
validated MS2 spectra resulting in 1541 assigned peptides from 347 different proteins in the 
library. The top twenty gene ontologies25 and KEGG pathways26 are shown in Figure 1. A 
complete list of the identified peptides and proteins from which they were derived are 
presented in Tables S1 and S2.
The protein-peptide model systems
To test the feasibility of screening for a specific protein-peptide binding within the 
peptidomic library, we first used the binding between calcium-activated calmodulin and a 
peptide spanning the calmodulin binding domain of endothelial nitric oxide synthase (eNOS, 
494-513) with a dissociation constant (Kd) of 2.9×10−9.27 Like many other peptide ligands 
of calmodulin,28 eNOS peptide folds into an α-helix upon binding to calcium-loaded 
calmodulin.29,30 In this context, calmodulin represents our protein target of interest. The 
objective of the screening was to identify peptide ligands that bound to calmodulin. eNOS 
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peptide was spiked into the library at an average ion abundance (11339 units) near median 
peptide abundance (6986 units). We used a large excess of calmodulin to drive the binding 
equilibrium to favor the bound state of the peptide and to ensure that the target was present 
in a sufficient excess that it could not be saturated by all potential peptide ligands. To 
demonstrate the generality of this approach and evaluate the detectable affinity range, we 
screened a second target protein, ribonuclease S (RNase S) using its S peptide ligand. The 
affinity between S peptide and RNase S, Kd = 1 × 10−7,31 is two orders of magnitude weaker 
than the calmodulin-eNOS peptide complex.
Gradient optimization
To minimize loss of deuterium label during the LC step, hydrogen exchange mass 
spectrometry workflows typically use short gradients of 15-30 minutes with only 5-10 
minutes devoted to the peptide separation. The 6200 peptides in the library exceeded the 
practical capacity of the LC-MS system to confidently discriminate isolated isotopic clusters 
in the mass spectra of each peptide within the time constraints imposed by the hydrogen 
exchange labeling. To overcome this problem, we developed three distinct gradient profiles 
(i.e., early, middle, and late) to disperse separate fractions of the library into the shallow, 
working part of the gradient (see Table 2). The early gradient used 2-19% B over ten 
minutes, the middle gradient used 12-24% B over twelve minutes, and the late gradient used 
26-95% B over ten minutes. The gradients and representative base peak chromatograms are 
shown in Figure 2. The use of three gradients allowed us to split the library into three nearly-
equal size hydrophobicity fractions as summarized in Table 3. Thus the total number of 
detectable library peptides in each HX-MS run was decreased from 6200 to between 1431 
and 2759. The sum total of features identified in the three gradients, 6664, exceeds the 6200 
identified in a single, long gradient because some of the peptides probably overlap between 
the gradients. Although this pool of peptide features is roughly ten-fold larger than routine 
HX-MS experiments, we have found that useful data can still be obtained from libraries of 
this size.
The E. coli-derived peptide library is diverse with respect to mass, abundance, and 
hydrophobicity, as shown in Figure 3. The peptide library had a median mass of 1003 Da 
with a range of 300-4000 (Figure 3a). The abundance of detectable features spanned two 
orders of magnitude (Figure 3b). Using the optimized three-gradient separation, the features 
were well-dispersed across the useful retention time window of two to twenty minutes 
(Figure 3c). This indicates the richness and complexity of the peptide library spanning 
hydrophilic to hydrophobic peptides.
Optimization of labeling conditions for screening for peptide binding
Conventional HX-MS experiments typically make use of forward exchange where a 
protiated sample (i.e., primarily 1H) is exposed to a large excess of D2O to promote H→D 
exchange. Due to the stochastic nature of the hydrogen exchange process, forward exchange 
leads to an unnatural isotopic distribution that is the convolution of the natural isotopic 
distribution with a binomial distribution arising from the hydrogen exchange process.32 
Conventional MS software is not well-suited for detection and analysis of the binomial 
distribution.33 Since our goal is to use hydrogen exchange to identify peptides that bind to a 
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protein target, we merely need to distinguish differential protection between the bound and 
unbound states of the peptide. To accomplish this, we have developed a D→H exchange 
workflow. We started with a pre-deuterated library of peptides prepared using 40% 
D2O/60% H2O buffer. The deuterated peptides were then diluted 1:10 into H2O in the 
presence and absence of the target protein. The workflow exploits rapid back-exchange by 
unbound peptides that causes them to undergo nearly complete back-exchange to the 
protiated form. Reversion to a near-natural isotopic distribution results in mass spectra with 
prominent monoisotopic peaks and isotopic distributions that closely resembles the natural 
distributions. Peptide spectra with a near-natural isotopic distribution and a well-defined 
monoisotopic mass peak are readily detected using mass spectrometry screening software. 
Since most peptides in the library do not bind to the target protein, most peptides have 
identical mass and nearly identical retention time in the presence and absence of the target 
protein. Mass spectral features that can be matched based on mass and retention time 
between the two conditions (i.e., presence and absence of the target protein) can be 
discarded as non-binders. Thus, our data analysis is reduced from examining all MS features 
to only identifying those few features that appear to be present in only one of the two states. 
To the screening software, the peptides appear to be unique in the two conditions because 
their monoisotopic masses differ by a few Da. The search for binders is reduced to cross-
validation of features that were classified as unique in either of the two conditions.
Detection of binding
Figure 4 illustrates the screening approach with the eNOS peptide. During 60 seconds of 
D→H exchange, eNOS bound to calmodulin retains a substantial amount of deuterium 
(Figure 4a) while free eNOS peptide undergoes nearly complete back-exchange (Figure 4b). 
Even in the highly complex peptide library, the spectra of eNOS were clean and well-
resolved (Figures 4cd). Based on its mass spectrum, eNOS exhibited similar protection from 
exchange when it bound to calmodulin in presence of the peptide library (Figure 4c) and free 
eNOS peptide exhibited the same level of back-exchange (Figure 4d). In contrast, other 
peptides exhibited identical back-exchange in both the presence and absence of calmodulin. 
Figures 4e and 4f show an example that illustrates the behavior of the majority of the 
features in the library during screening: the features had the same mass in both conditions 
indicating no binding to calmodulin. Since this peptide had the same mass and retention time 
under both conditions, it was removed from the candidate binder list. The goal of the 
screening workflow was to identify features that exhibited positive mass shifts in the 
presence of calmodulin. The entire list of peptide features was filtered to identify apparently 
unique peptides in the presence vs. the absence of the binding protein.
Detection of peptides that bound to calmodulin required identification of MS features with 
similar, but not identical masses, with nearly the same retention time. As a first pass, Mass 
Profiler was used to identify features that appeared to be unique in either condition. Here, 
unique means that a feature, detected in at least two of the three runs in one condition, could 
not be matched in at least two of three runs in the other condition. Table 3 summarizes the 
results from this analysis, applied to the screening of a library of E. coli peptides for binding 
to calmodulin. A total of 6664 features were detected in at least two of the three runs for one 
of the two conditions. Of these features, 406 appeared to be unique in the presence of 
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calmodulin while 695 appeared to be unique to the screening of the calmodulin-free library. 
These 1101 features were classified as potential calmodulin binding peptides. Under D → H 
labeling conditions, a true binder will be more protected against exchange when it is bound 
to the target protein. Thus, the mass signature of a binding peptide is that it will have a 
higher mass in the presence of the target than a feature with nearly the same retention time 
in the absence of the target. To identify potential binders, the features were subjected to pair-
wise comparisons (the presence vs. the absence of calmodulin) to identify potential binders 
based on retention time and mass proximity according to the following rules
(1)
(2)
where t and m denote the retention time and mass, respectively, and the subscripts indicate 
the presence or absence of the target protein (here, calmodulin). 117 peptide pairs that 
satisfied both criteria were flagged for inspection. The mass spectra the features in both 
states were examined to determine if they had isotopic distributions like those shown in 
Figure 4b and 4d. Except for eNOS peptide, all of the flagged peptides were false positives 
that generally arose from failures in peak picking by the Find by Molecular Feature 
algorithm caused by misassignment of the monoisotopic peak, from chemical noise in the 
mass spectrum, or from features that could not be matched to a similar feature in the other 
condition. A few examples of false positive results are shown in Figure S2 of the supporting 
information. Only the eNOS peptide (Figure 4cd) exhibited an isotopic distribution and mass 
shift that would be expected for a peptide undergoing differential hydrogen exchange in the 
presence/absence of calmodulin.
As summarized in Table 3, this workflow led to the identification of only a single peptide 
ligand, eNOS, against the target protein calmodulin within a complex sample library 
composed of ∼6000 detectable features. The true makeup of the peptide library, derived 
from proteolysis of E. coli lysate, is certainly more complex than these ∼6000 features 
analyzed. Limits are imposed by chemical noise, the dynamic range of the mass 
spectrometer, and the combined resolving power of the LC and MS dimensions.
A limited screening of the E. coli library spiked with S peptide against RNase S was used to 
assess the effects of weaker binding and to determine if the screening process was directly 
transferable to another protein-ligand system. In this case, the elution of the S peptide in the 
early gradient was known a priori, so only the early gradient was evaluated. As with the 
eNOS peptide, S peptide also exhibited a higher level of deuteration in the presence of 
ribonuclease S (see Figure S3 in the Supporting Information), but the mass shift was smaller. 
The smaller mass shift is consistent with the lower affinity, Kd ≈ 1 × 10−7 of RNase S for its 
ligand.31 Screening and data analysis were conducted without any additional optimization. 
The results of the RNase S screening are presented in Table 4. As with calmodulin 
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screening, only a single hit, S peptide, was ultimately confirmed. In RNase S screening, 
although the same E. coli proteome and proteolysis process was used for library production, 
fewer total peptides were detected in the early gradient (874 vs. 2474). The apparent loss of 
peptides may arise from differences in total lysate digested, differences in enzyme 
efficiency, or variability in sample loading. This lack of reproducibility result highlights a 
challenge in preparation of peptide libraries directly from cell lysates.
Discussion
Using ligand screening strategies such as phage display and one-bead one-compound 
enables the rapid screening of libraries of random peptides as large as 1010. However, there 
are significant drawbacks to these approaches that arise from the need to tether the peptides. 
In phage display, for example, the peptides are fused to the phage coat protein. Constraining 
one or usually both termini and placing the entire peptide close to the coat surface can lead 
to the presentation of non-native conformations, prevent exposure of a viable binding 
interface, or prevent the peptide from adopting a binding-competent conformation. Thus the 
screening of free peptides in solution is attractive, because the solution conformation of the 
peptide ligand is preserved. In this work, we have demonstrated that free peptides in small 
libraries can be directly screened for binding to a target of interest.
Using current practices, the practical limit in HX-MS analysis seems to be pools of a few 
hundred peptides34 as reported in challenging HX-MS experiments such as large protein 
complexes35 or monoclonal antibody studies.36 Here, hydrogen exchange analysis of 6664 
peptide features is probably the largest number of peptide features analyzed in a single 
experimental effort. It represents, nevertheless, perhaps 2-3% of the number of peptides 
expected based on in silico digests of the E. coli proteome. Though the potential of using a 
proteome as a rational chemical space for peptide ligands is highly attractive, it may be 
difficult to use the approach outlined here to achieve the peak capacity required to fully 
characterize such a library. E. coli lysate was used here because it was a relatively simple 
approach for the production of a large, complex peptide library. A eukaryotic protein-peptide 
interaction was deliberately added to minimize the probability that a ligand would already be 
present in the library. It is likely that the 6664 peptides screened in the present work 
represent high-abundance proteins. Indeed, as shown in Figure 1, the majority of the 
peptides identified in our library are associated with transcription and translation.
While proteome-scale resolution is unlikely to be achievable, we do anticipate that further 
improvements would be able to increase capacity by factor of ten to one hundred. This 
would enable the screening of libraries on the order of 106 peptides. Increasing mass 
spectrometer resolution from 104 to 105 by switching from time-of-flight to orbitrap would 
result in a significant increase in peak capacity. Changing from narrow bore (2.1 mm 
diameter) LC columns operating at 200 μL min−1 flow rate down to capillary dimensions 
would increase the capacity by lowering the limit of detection. Use of capillary 
electrophoresis might further enhance the peak capacity.37 This screening method may also 
be useful with libraries produced using targeted proteomic approaches such as subcellular 
fractionation or pull-downs of protein complexes. Finally, libraries of proteome-derived 
peptides could be pre-fractionated by cation exchange with each cation exchange fraction 
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screened separately. Furthermore, if the library was synthetic, rather than proteome-derived, 
the dynamic range of the sample would no longer impose such an obstacle to detection and a 
decrease in chemical noise from sample preparation could result in further improvement.
Ultimately, the limit of detection for binding will depend on whether there is a discernable 
mass difference in the presence/absence of the target. Both peptide size and affinity for the 
target will define this limit of detection. First, larger peptides have more amide hydrogens. 
Thus larger peptides will have larger mass shifts than smaller peptides. In conventional 
hydrogen exchange experiments, mass differences of ∼0.5 Da or more are typically reported 
as significant,38 in other words, detectable. Here however, the data analysis relies on loss of 
the monoisotopic peak rather than mass increase, per se. Still, the overall mass increase 
determines whether the monoisotopic peak is rendered undetectable. The extent of 
protection from hydrogen exchange will also depend on the interplay between the kinetics of 
peptide binding and release with the kinetics of the hydrogen exchange process. Peptide 
ligand, when transiently unbound, will undergo much faster hydrogen exchange, but this 
effect will only be important if the lifetime of the unbound peptide is comparable to lifetime 
of amide hydrogen exchange (approximately 0.1-10 s at pH 7).39 The lifetime of unbound 
ligand, in turn depends on the concentration of the target protein. A large excess of target 
protein was used in this work to saturate the bound state of the ligands in order to minimize 
rapid D→H exchange by the transiently unbound peptide ligand.
In this work, our data analysis relied on the loss of monoisotopic peak to classify peptides as 
potential binders. Although a number of different software suites are now available for the 
analysis of hydrogen exchange mass spectrometry data,40 these packages all require detailed 
knowledge of the peptides of interest. In particular, the amino acid sequence and retention 
time window for each peptide must be known in advance. Because we are screening large 
libraries of unknown peptides, we selected a binary classifier, a shift in the apparent 
monoisotopic peak, that was readily applied using off-the-shelf software. The rate of false 
positives, and the need for manual review, could be substantially decreased by 
implementation of a deuterated isotopic profile analysis of candidates that pass the initial 
screening.
Beyond the screening described here that was used to identify a known protein-peptide 
interaction, further developments in the workflow would be required to detect and identify 
novel peptide ligands. In particular, tandem mass spectrometry would need to be 
incorporated into the workflow. Since the fully back-exchanged control state is available, 
there would be no issues with deuterium scrambling that can be encountered during 
precursor fragmentation. Absence of deuteration would also facilitate peptide identification 
by database searching. Finally, hits identified by this technique require confirmation: 
interactions between peptide ligands and targets would need to be confirmed by follow-up 
assays such as fluorescence polarization or surface plasmon resonance.
One particular advantage of the approach described here is that screening is a one-pot 
process involving free peptides in solution. Thus it is not necessary to isolate the individual 
library members as is done in well plate assays or one-bead-one-compound screening. 
Furthermore, the analysis time is not a strong function of the library size as long as the peak 
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capacity is not exceeded. Based on this work, it would require no additional time to screen a 
library of 20000 instead of 6000 peptides
We anticipate several different areas where the advantages of this screening approach may 
be valuable. The first area is the discovery of potential leads to inhibit protein-protein 
interactions. Here two alternative modes are possible. In the direct mode, the discovered 
ligand itself is used in hit-to-lead to discover protein-protein interaction inhibitors. In the 
second mode, the ligand could be used as the displaceable ligand in high throughput 
competition assays. Beyond screening, the hydrogen exchange labeling and data analysis 
workflow we have described may prove useful in conventional comparative HX-MS 
experiments where there are only a small number of differences between two protein states. 
The technique might also be useful for development of designed antibodies: the screening is 
orthogonal to an approach in which the Protein Data Bank was mined to identify potential 
paratopes against β-sheet regions of disordered proteins.41
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Prof. Trevor Creamer of the University of Kentucky for the donation of calmodulin. An equipment loan 
from Agilent Technologies is gratefully acknowledged. Mohammed Al-Naqshabandi and Tyler Hageman provided 
critical readings of the manuscript. This project was supported by grant P30GM103495 from the National Institute 
of General Medical Sciences at the National Institutes of Health.
References
1. Gray BP, Brown KC. Chem Rev. 2014; 114:1020. [PubMed: 24299061] 
2. Arkin MR, Whitty A. Curr Opin Chem Biol. 2009; 13:284. [PubMed: 19553156] 
3. Goeke D, Kaspar D, Stoeckle C, Grubmüller S, Berens C, Klotzsche M, Hillen W. J Mol Biol. 2012; 
416:33. [PubMed: 22178480] 
4. Landgraf KE, Steffek M, Quan C, Tom J, Yu C, Santell L, Maun HR, Eigenbrot C, Lazarus RA. Nat 
Chem Biolo. 2014; 10:567.
5. Arkin MR, Wells JA. Nat Rev Drug Discov. 2004; 3:301. [PubMed: 15060526] 
6. Wells JA, McClendon CL. Nature. 2007; 450:1001. [PubMed: 18075579] 
7. Liu R, Enstrom AM, Lam KS. Experimental Hematology. 2003; 31:11. [PubMed: 12543103] 
8. Smith GP, Petrenko VA. Chem Rev. 1997; 97:391. [PubMed: 11848876] 
9. Daugherty PS. Curr Opin Struct Biol. 2007; 17:474. [PubMed: 17728126] 
10. Bratkovič T. Cellular and Molecular Life Sciences. 2010; 67:749. [PubMed: 20196239] 
11. Lam KS, Salmon SE, Hersh EM, Hruby VJ, Kazmierski WM, Knapp RJ. Nature. 1991; 354:82. 
[PubMed: 1944576] 
12. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Nature. 1991; 354:84. 
[PubMed: 1719428] 
13. Lam, KS., Lehman, AL., Song, A., Doan, N., Enstrom, AM., Maxwell, J., Liu, R. Methods in 
enzymology. Vol. 369. Academic Press; 2003. p. 298
14. Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS. Molecular Pharmaceutics. 2007; 4:631. 
[PubMed: 17880166] 
15. Keppel TR, Howard BA, Weis DD. Biochemistry. 2011; 50:8722. [PubMed: 21894929] 
16. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Nat Meth. 2009; 6:359.
Maaty and Weis Page 12













17. Sharma R, Dill BD, Chourey K, Shah M, Ver Berkmoes NC, Hettich RL. J Proteome Res. 2012; 
11:6008. [PubMed: 23126408] 
18. Wisniewski JR, Mann M. Anal Chem. 2012; 84:2631. [PubMed: 22324799] 
19. Erde J, Loo RR, Loo JA. J Proteome Res. 2014; 13:1885. [PubMed: 24552128] 
20. Giannone RJ, Wurch LL, Podar M, Hettich RL. Anal Chem. 2015; 87:7720. [PubMed: 26110888] 
21. Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, Martens L, Barsnes H. 
Nat Biotech. 2015; 33:22.
22. Charbonneau, H., Hice, R., Hart, RC., Cormier, MJ. Methods in enzymology. Vol. 102. Academic 
Press; 1983. p. 17
23. Rumi-Masante J, Rusinga FI, Lester TE, Dunlap TB, Williams TD, Dunker AK, Weis DD, 
Creamer TP. J Mol Biol. 2012; 415:307. [PubMed: 22100452] 
24. Richards FM, Vithayathil PJ. J Biol Chem. 1959; 234:1459. [PubMed: 13654398] 
25. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight 
SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson 
JE, Ringwald M, Rubin GM, Sherlock G. Nature genetics. 2000; 25:25. [PubMed: 10802651] 
26. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. Nucleic Acids Res. 2012; 40:D109. 
[PubMed: 22080510] 
27. Matsubara M, Hayashi N, Titani K, Taniguchi H. J Biol Chem. 1997; 272:23050. [PubMed: 
9287303] 
28. Crivici A, Ikura M. Ann Rev Biophys Biomolec Struct. 1995; 24:85.
29. Aoyagi M, Arvai AS, Tainer JA, Getzoff ED. EMBO J. 2003; 22:766. [PubMed: 12574113] 
30. Piazza M, Taiakina V, Guillemette SR, Guillemette JG, Dieckmann T. Biochemistry. 2014; 
53:1241. [PubMed: 24495081] 
31. Connelly PR, Varadarajan R, Sturtevant JM, Richards FM. Biochemistry. 1990; 29:6108. [PubMed: 
2383573] 
32. Arrington CB, Teesch LM, Robertson AD. J Mol Biol. 1999; 285:1265. [PubMed: 9887275] 
33. Sarpe, V., Schriemer, DC. Hydrogen exchange mass spectrometry: Theory, techniques, and 
applications. Weis, DD., editor. Wiley; in press
34. Engen JR, Wales TE. Annu Rev Anal Chem. 2015; 8:127.
35. Houde D, Demarest Stephen J. Structure. 2011; 19:890. [PubMed: 21645859] 
36. Arora J, Hickey JM, Majumdar R, Esfandiary R, Bishop SM, Samra HS, Middaugh CR, Weis DD, 
Volkin DB. mAbs. 2015; 7:525. [PubMed: 25875351] 
37. Black WA, Stocks BB, Mellors JS, Engen JR, Ramsey JM. Anal Chem. 2015; 87:6280. [PubMed: 
25992468] 
38. Houde D, Berkowitz SA, Engen JR. J Pharm Sci. 2011; 100:2071. [PubMed: 21491437] 
39. Bai Y, Milne JS, Mayne L, Englander SW. Proteins. 1993; 17:75. [PubMed: 8234246] 
40. Iacob R, Engen J. J Amer Soc Mass Spectrom. 2012; 23:1. [PubMed: 22076632] 
41. Sormanni P, Aprile FA, Vendruscolo M. Proc Natl Acad Sci USA. 2015; 112:9902. [PubMed: 
26216991] 
Maaty and Weis Page 13














(a) The top twenty gene ontologies (GO terms)25 and (b) top twenty pathways (KEGG 
annotation)26 of the E. coli proteins identified in the peptide library.
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Base-peak chromatograms (solid lines) and their corresponding gradients (dashed lines) for 
separation of the peptide library into three separate fractions, (a) early, (b) middle, (c) and 
late. For the base-peak chromatograms, the vertical axis is base ten logarithmic. See Table 1 
for the gradient time tables and Table 2 for the number of peptides observed in each 
separation.
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Characteristics of the E. coli library peptides. The asterisks (*) donate the characteristics of 
eNOS peptide. Distributions of their (a) masses, (b) MS abundances, and (c) LC retention 
times. Only peptides found in the shallow portions of the gradients (see Table 2) are 
presented. The numbers on the horizontal axes the upper limit of the bins.
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Representative hydrogen exchange mass spectra showing mass shifts observed during D → 
H exchange. (a)-(d) show the spectrum of the eNOS peptide, (e) and (f) are of E.coli D-
ribose-binding periplasmic protein (P02925) peptide 165LAATIAQLPDQIGAK179. In the 
presence of calcium-loaded calmodulin, eNOS peptide experiences less hydrogen exchange 
(a) than it does when calmodulin is absent (b). The hydrogen exchange characteristics of the 
eNOS peptide are similar when the hydrogen exchange screening is applied in the presence 
of the peptide library (c and d). Other peptides in the library show no difference in hydrogen 
exchange in the presence/absence of calmodulin (e and f).
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Table 1
Analysis of the E. coli peptide library by LC-MS2 with collision induced dissociation.
MS2 spectra acquired 40241





Abbreviations: GO (gene ontology); KEGG (Kyoto Encyclopedia of Genes and Genomes).
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Table 3
Results from screening the eNOS peptide-spiked E. coli peptide library for binding to calmodulin.
Early gradient Middle Gradient Late Gradient Total
Identified features 2474 2759 1431 6664
Unique (– calmodulin) 174 306 215 695
Unique (+ calmodulin) 186 125 95 406
Identified hits1 28 43 46 117
Confirmed hits2 0 1 0 1
1
Hits were identified on the basis of altered hydrogen exchange using the criteria in equations (1) and (2).
2
Hits were confirmed by inspection of the extracted spectra as illustrated in Figures 4 and S2.
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Table 4
Results from screening the S peptide-spiked E. coli peptide library for binding to ribonuclease S.
Early gradient
Identified features 874
Unique (– ribonuclease S) 51




Hits were identified on the basis of altered hydrogen exchange using the criteria in equations (1) and (2).
2
Hits were confirmed by inspection of the extracted spectra as illustrated in Figure S3.
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